Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[¹⁴C] Hydronidone Mass Balance Study in Chinese Healthy Adult Male Participants

NCT07471217 is registered in ClinicalTrials.gov with Beijing Continent Pharmaceutical Co, Ltd. as lead sponsor.

NCT NCT07471217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07471217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[¹⁴C] Hydronidone Mass Balance Study in Chinese Healthy Adult Male Participants
Lead sponsor
Beijing Continent Pharmaceutical Co, Ltd.
Phase
Phase 1
Overall status
Completed
Start date
April 17, 2026
Completion date
May 6, 2026
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b-related liver fibrosis